הודעות לעיתונות

June 14, 2010
Taro Provides Preliminary First Quarter 2010 Financial Results
More

June 03, 2010
Taro Receives FDA Approval for Granisetron Hydrochloride Tablets
More

April 30, 2010
Taro Provides Preliminary 2009 Full Year Results
More

April 06, 2010
Taro Receives Patent for T2007, the Company's Second Proprietary Non-Sedating Barbiturate Drug
More

March 25, 2010
Taro Files Audited Financials for the Year Ended December 31, 2006 and Restated Financials for 2005 and 2004
More

March 8, 2010
Taro Receives FDA Approval for Fluorouracil Topical Cream USP, 5%
More

February 18, 2010
Taro Announces Planned Discontinuation of Manufacturing Operations at Its Irish Facility
More

February 4, 2010
Israel Supreme Court Prohibits Sun From Exercising Warrant While Temporary Junction In Affect
More

February 2, 2010
Taro Receives FDA Approval For Levetiracetam Tablets
More